Literature DB >> 1521538

Site-specific mutagenesis of Escherichia coli asparaginase II. None of the three histidine residues is required for catalysis.

A Wehner1, E Harms, M P Jennings, I R Beacham, C Derst, P Bast, K H Röhm.   

Abstract

Site-specific mutagenesis was used to replace the three histidine residues of Escherichia coli asparaginase II (EcA2) with other amino acids. The following enzyme variants were studied: [H87A]EcA2, [H87L]EcA2, [H87K]EcA2, [H183L]EcA2 and [H197L]EcA2. None of the mutations substantially affected the Km for L-aspartic acid beta-hydroxamate or impaired aspartate binding. The relative activities towards L-Asn, L-Gln, and l-aspartic acid beta-hydroxamate were reduced to the same extent, with residual activities exceeding 10% of the wild-type values. These data do not support a number of previous reports suggesting that histidine residues are essential for catalysis. Spectroscopic characterization of the modified enzymes allowed the unequivocal assignment of the histidine resonances in 1H-NMR spectra of asparaginase II. A histidine signal previously shown to disappear upon aspartate binding is due to His183, not to the highly conserved His87. The fact that [H183L]EcA2 has normal activity but greatly reduced stability in the presence of urea suggests that His183 is important for the stabilization of the native asparaginase tetramer. 1H-NMR and fluorescence spectroscopy indicate that His87 is located in the interior of the protein, possibly adjacent to the active site.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1521538     DOI: 10.1111/j.1432-1033.1992.tb17210.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  10 in total

1.  The glutaminase activity of L-asparaginase is not required for anticancer activity against ASNS-negative cells.

Authors:  Wai Kin Chan; Philip L Lorenzi; Andriy Anishkin; Preeti Purwaha; David M Rogers; Sergei Sukharev; Susan B Rempe; John N Weinstein
Journal:  Blood       Date:  2014-03-21       Impact factor: 22.113

2.  Identification of functional regions in the Rhodospirillum rubrum L-asparaginase by site-directed mutagenesis.

Authors:  M V Pokrovskaya; S S Aleksandrova; V S Pokrovsky; A V Veselovsky; D V Grishin; O Yu Abakumova; O V Podobed; A A Mishin; D D Zhdanov; N N Sokolov
Journal:  Mol Biotechnol       Date:  2015-03       Impact factor: 2.695

3.  Engineering the substrate specificity of Escherichia coli asparaginase. II. Selective reduction of glutaminase activity by amino acid replacements at position 248.

Authors:  C Derst; J Henseling; K H Röhm
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

4.  Crystal structure of Escherichia coli L-asparaginase, an enzyme used in cancer therapy.

Authors:  A L Swain; M Jaskólski; D Housset; J K Rao; A Wlodawer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-02-15       Impact factor: 11.205

5.  L-asparaginase of Thermus thermophilus: purification, properties and identification of essential amino acids for its catalytic activity.

Authors:  A A Pritsa; D A Kyriakidis
Journal:  Mol Cell Biochem       Date:  2001-01       Impact factor: 3.396

6.  Co-occurrence of both L-asparaginase subtypes in Arabidopsis: At3g16150 encodes a K+-dependent L-asparaginase.

Authors:  Luanne Bruneau; Ralph Chapman; Frédéric Marsolais
Journal:  Planta       Date:  2006-05-10       Impact factor: 4.116

7.  Mutations in subunit interface and B-cell epitopes improve antileukemic activities of Escherichia coli asparaginase-II: evaluation of immunogenicity in mice.

Authors:  Ranjit Kumar Mehta; Shikha Verma; Rashmirekha Pati; Mitali Sengupta; Biswajit Khatua; Rabindra Kumar Jena; Sudha Sethy; Santosh K Kar; Chitra Mandal; Klaus H Roehm; Avinash Sonawane
Journal:  J Biol Chem       Date:  2013-12-02       Impact factor: 5.157

8.  Crystal structure and allosteric regulation of the cytoplasmic Escherichia coli L-asparaginase I.

Authors:  Mi-Kyung Yun; Amanda Nourse; Stephen W White; Charles O Rock; Richard J Heath
Journal:  J Mol Biol       Date:  2007-03-30       Impact factor: 5.469

9.  Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase.

Authors:  Wei-Wen Chien; Soraya Allas; Nicolas Rachinel; Pierre Sahakian; Michel Julien; Céline Le Beux; Claire-Emmanuelle Lacroix; Thierry Abribat; Gilles Salles
Journal:  Invest New Drugs       Date:  2014-05-15       Impact factor: 3.850

Review 10.  Molecular Analysis of L-Asparaginases for Clarification of the Mechanism of Action and Optimization of Pharmacological Functions.

Authors:  Marina V Pokrovskaya; Vadim S Pokrovsky; Svetlana S Aleksandrova; Nikolay N Sokolov; Dmitry D Zhdanov
Journal:  Pharmaceutics       Date:  2022-03-09       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.